HOW TO INDIVIDUALIZE RENOPROTECTIVE THERAPY IN OBESE PATIENTS WITH CHRONIC KIDNEY DISEASE: A COMMENTARY BY THE DIABESITY WORKING GROUP OF THE ERA

Descargar Publicación
GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer La contaminación del aire puede contribuir a la obesidad y la diabetes